A Study of LY900014 in a Medtronic Pump

Completed · Phase 2

Conditions studied: Type1 Diabetes Mellitus

In brief

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D). The study will consist of two treatment periods of 4 weeks.

Key facts

Study ID

NCT03760640

Run by

Eli Lilly and Company

People needed

42

Starts

2019-02-18

Expected to finish

2019-10-07

Last updated by the study team

2020-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must have been diagnosed with type 1 diabetes and have been using insulin continuously for at least 12 months
• Participants must be using an insulin pump with "rapid-acting insulin" for at least 6 months and the same "rapid acting insulin" for at least the past 30 days
• Participants must have hemoglobin A1c (HbA1c) values ≥6.0% and ≤8.0%
• Participants must have been using the MiniMed 670G insulin pump for at least the past 90 days
• Participants must use their Guardian (3) sensor at least an average of 75% of the time and remain in Auto Mode an average of 70% of the time

You may not qualify if…

• Participants must not have had more than 1 emergency treatment for very low blood glucose or any hospitalizations for poor glucose control (very high blood sugar or diabetic ketoacidosis) in the last 6 months
• Participants must not have significant abnormal accumulation of fat, loss of fat tissue, or scars just under the skin in areas of infusion or have a history of an infection at an infusion site within 90 days prior to screening
• Participants must not have a total daily insulin dose >100 units
• Participants must not be receiving any oral or injectable medication intended for the treatment of diabetes other than rapid-acting analog insulin via CSII in the 30 days prior to screening
• Participants must not have major problems with their heart, kidneys, liver, or have a blood disorder

Where it is running

• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• International Diabetes Center — Saint Louis Park, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.